Stock listing
Lang & Schwarz:A3EFB5 MindMaze Therapeutics Holding SA Aktie
German listing (Lang & Schwarz) of MindMaze Therapeutics Holding SA · home listing SIX Swiss:MMTX
Follow MindMaze Therapeutics Holding SA into a list and get an email when it puts out news.
Home listing price · SIX:MMTX
0.152 CHF +0.007 (+5.0%)
Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:MMTX
- Day range
- 0.147 – 0.154 CHFOct 16, 2026
- Volume
- 976,145 sharesOct 16, 2026
- Market value
- 25.81M CHFAt the close on Oct 16, 2026 · price × 170.0M shares outstanding
- Ticker
- Lang & Schwarz:A3EFB5
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 17, 2026
MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
Financings
Strategic investment of treasury shares and mandatory convertible loan notes converted into ordinary shares
Aug 10, 2026 · US$4.94M
Tranche closed: CHF 4M raised
Buyers: Neuro.io Group SA (CHF 8.0 million strategic equity financing; first tranche of CHF 4.0 million completed, second CHF 4.0 million tranche expected in September and November 2026)
Use of proceeds: Support U.S. commercial priorities and advancement of the neurotherapeutics platform
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · September 2026
Investor Presentation (March 2026)
Investor deck · 20 slides · March 2026
Investor Presentation (October 2025)
Investor deck · 35 slides · October 2025
MindMaze Therapeutics Holding SA on 6ix
- News releases
- 18 in the last 12 months · 18 in all · newest Sep 17, 2026 · oldest 2025
- Decks
- 3 decks · latest September 2026
Where MindMaze Therapeutics Holding SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:MMTX · Home listing | SIX Swiss | Switzerland | CHF |
| OTC:RLFTF | OTC | United States | USD |
| OTC:RLFTY | OTC | United States | USD |
| LSE:0QKQ | LSE | United Kingdom | CHF |
| Lang & Schwarz:A3EFB5 · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3EFB5 | LS Exchange | Germany | EUR |
| Aquis:MMTXZ | Aquis | United Kingdom | CHF |
| gettex:V6M | gettex | Germany | EUR |
| BX Swiss:MMTX | BX Swiss | Switzerland | CHF |
| Munich:V6M | Munich | Germany | EUR |
| Turquoise:MMTXZ | Turquoise | United Kingdom | CHF |
| Frankfurt:V6M | Frankfurt | Germany | EUR |
| Munich:V6M1 | Munich | Germany | EUR |
| Stuttgart:V6M | Stuttgart | Germany | EUR |
| OTC:MMTZF | OTC | United States | USD |
Log in to ask 6ix AI your own questions about MindMaze Therapeutics Holding SA.